Cleared Traditional

K212875 - Spectral CT on Rails

K212875 is the FDA 510(k) clearance for Spectral CT on Rails by Philips Medical Systems Nederland B.V.. It is a Class 2 Radiology device (product code JAK) cleared through the Traditional 510(k) pathway after a 246-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2022
Decision
246d
Days
Class 2
Risk

K212875 is an FDA 510(k) clearance for the Spectral CT on Rails. Classified as System, X-ray, Tomography, Computed (product code JAK), Class II - Special Controls.

Submitted by Philips Medical Systems Nederland B.V. (Best, NL). The FDA issued a Cleared decision on May 13, 2022 after a review of 246 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1750 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Philips Medical Systems Nederland B.V. devices

Submission Details

510(k) Number K212875 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 09, 2021
Decision Date May 13, 2022
Days to Decision 246 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
139d slower than avg
Panel avg: 107d · This submission: 246d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JAK System, X-ray, Tomography, Computed
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - JAK System, X-ray, Tomography, Computed

All 581
Devices cleared under the same product code (JAK) and FDA review panel - the closest regulatory comparables to K212875.
Aquilion ONE (TSX-306A/3) V10.12 with Spectral Imaging System, Vitrea Software Package, VSTP-001A
K213504 · Canon Medical Systems Corporation · Jun 2022
SCENARIA View
K213829 · Fujifilm Healthcare Corporation · May 2022
syngo.CT CaScoring
K221219 · Siemens Medical Solutions USA, Inc. · May 2022
XACT ACE Robotic System
K221116 · Xact Robotics, Ltd. · May 2022
NewTom 7G
K220664 · Cefla S.C. · May 2022
Liver Suite
K211180 · GE Medical Systems SCS · May 2022